Research progress on the roles of aldose reductase in diabetic retinopathy
Aldose reductase(AR)belonging to nicotinamide-adenine dinucleotide phosphate(NADPH)-dependent aldehyde-keto reductase superfamily, is the key rate-limiting enzyme in the polyol pathway which plays an important role in the body's high-sugar metabolism. AR is widely present in the kidneys, blood...
Main Authors: | Hong-Zhe Li, Cai-Rui Li, Shu-Guang Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2015-07-01
|
Series: | Guoji Yanke Zazhi |
Subjects: | |
Online Access: | http://ies.ijo.cn/cn_publish/2015/7/201507015.pdf |
Similar Items
-
Aldose Reductase: An Emerging Target for Development of Interventions for Diabetic Cardiovascular Complications
by: Sravya Jannapureddy, et al.
Published: (2021-03-01) -
In Search of Differential Inhibitors of Aldose Reductase
by: Francesco Balestri, et al.
Published: (2022-03-01) -
The use of dimethylsulfoxide as a solvent in enzyme inhibition studies: the case of aldose reductase
by: Livia Misuri, et al.
Published: (2017-01-01) -
Dietary aldose reductase inhibitors and prevention of diabetic complications
by: Ameena Anjum, et al.
Published: (2021-01-01) -
Demethylbellidifolin, a potential aldose reductase inhibitor ameliorates diabetic nephropathy by regulating the polyol pathway
by: Haifei Xie, et al.
Published: (2022-02-01)